Australia–New Zealand: TGA and Medsafe joint Trans-Tasman framework — monitor TPA commencement
2026-12-31 — Australia–New Zealand: TGA and Medsafe joint Trans-Tasman framework — monitor TPA commencement
New Zealand's Therapeutic Products Act 2023 (TPA) is expected to commence via regulations to be made by the New Zealand government. Once in force, it will replace the current WAND voluntary notification system with mandatory conformity assessment requirements for medical devices.
For manufacturers already registered with TGA (Australia), the TPA is expected to include provisions recognising TGA conformity assessment — the trans-Tasman regulatory cooperation model means a TGA listing may provide a streamlined pathway for New Zealand under the new TPA framework.
Monitor both Medsafe (New Zealand) and TGA (Australia) announcements for:
- The TPA commencement date (subject to New Zealand government regulations)
- Transitional arrangements for devices currently notified on WAND
- Recognition provisions for TGA-registered devices under TPA
Verify the current TPA commencement status directly with Medsafe before planning your New Zealand regulatory strategy.
View official source ↗